Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: amoxicillin attending: chief complaint: chronic drainage/infection of ec fistulae major surgical or invasive procedure: s/p ex-lap/loa, resection of ileum, re-siting of ileostomy history of present illness: the patient is a 38-year-old male with crohn's disease who has previously undergone a total abdominal colectomy and end ileostomy. he had a midline ventral hernia by palpation. he has been treated with remicade somewhat successfully for parastomal fistulae. he abruptly developed five new fistulae with evidence of infection and abdominal wall phlegmon. he was admitted to the hospital, treated with iv antibiotics, local care and tpn. local symptoms dramatically improved and resection of this portion of bowel and reciting was recommended. past medical history: crohn's disease dx , s/p total colectomy , enterocutaneous fistula peri-stomal inflammation/absesses/ecf treated with remicaid/antibiotics (ecf now closed) perianal fistulas status post parastomal hernia repair w/ mesh status post open ccy complicated by small bowel injury (primary repair) appendectomy in s/p cholecystecomy social history: no tobacco, occasional alcohol family history: noncontributory no fh of ibd physical exam: ed exam vitals: t-99.6, hr-107, bp-146/85, rr-16, o2 sat-98% ra const: a/ox 3, nad head/eyes: eomi resp: ctab cv:nml s1/s2, no m/r/g abd:soft, rlq ostomy, stoma pink. ostomy site surrounded by several areas of drainage/pus/cellulitis, marked erythema, entire lower area extrem: no edema skin: dry intact besides cellulitis described above psych: normal mood/mentation pertinent results: 07:47am blood wbc-10.9 rbc-4.14* hgb-11.2* hct-33.4* mcv-81* mch-27.0 mchc-33.5 rdw-15.9* plt ct-343 03:31am blood wbc-25.3* rbc-4.74 hgb-12.7* hct-38.1* mcv-80* mch-26.7* mchc-33.3 rdw-16.0* plt ct-293 05:35pm blood wbc-15.9*# rbc-5.23 hgb-14.5 hct-43.0 mcv-82# mch-27.7# mchc-33.6 rdw-15.8* plt ct-405 07:47am blood neuts-81* bands-1 lymphs-10* monos-5 eos-2 baso-0 atyps-1* metas-0 myelos-0 02:02am blood pt-15.4* ptt-33.1 inr(pt)-1.4* 07:47am blood glucose-73 urean-19 creat-0.9 na-135 k-4.0 cl-104 hco3-24 angap-11 05:35pm blood glucose-94 urean-13 creat-1.1 na-140 k-3.9 cl-104 hco3-28 angap-12 09:55am blood alt-29 ast-29 alkphos-75 totbili-0.2 07:47am blood calcium-8.2* phos-3.8 mg-2.0 09:55am blood caltibc-276 ferritn-62 trf-212 04:14pm blood triglyc-152* 09:55am blood triglyc-85 12:05pm blood asa-neg ethanol-neg acetmnp-neg bnzodzp-neg barbitr-neg tricycl-neg 03:43am blood lactate-1.4 05:49pm blood lactate-2.1* 03:43am blood freeca-1.06* . radiology final report ct pelvis w/contrast 10:50 pm ct abdomen w/contrast; ct pelvis w/contrast clinical indication: patient with crohn's with peristomal fistula and abscess. impression: findings consistent with inflammation of the patient's neoterminal ileum as detailed above with suggestion of small abscess and possible sinus tracts as noted. . pathology examination procedure date diagnosis: ileostomy and small bowel resection (a-d): 1. chronic severely active ileitis with ulceration and transmural inflammation extending to the ileostomy site and margins of separate small bowel resection. (see note.) 2. changes consistent with ileostomy. note: the features are consistent with crohn's disease in the appropriate clinical setting. clinical: enterocutaneous fistula. . mrsa screen mrsa screen-final--no growth swab r/o vancomycin resistant enterococcus-final mrsa screen mrsa screen-final--no growth blood culture aerobic bottle-final; anaerobic bottle-final--no growth swab gram stain-final; fluid culture-final {staphylococcus, coagulase negative}; anaerobic culture-final swab gram stain-final; wound culture-final {yeast, viridans streptococci} urine urine culture-final--no growth blood culture aerobic bottle-final; anaerobic bottle-final--no growth blood culture aerobic bottle-final; anaerobic bottle-final--no growth brief hospital course: mr. was evaluated in ed, and admitted for management of cellulitis, draining fistulae, and possible abscess at fistula site acording to abd/pelvic ct scan obtained in ed. blood and urine cultures were collected. . hd1-3:he was evaluated per gi on hd1. according to gi recommendations, he was managed with iv antibiotics, npo status, and remicade was held due to possible surgery for ostomy re-location. all cultures and vancomycin levels were followed, and picc insertion was initiated. the patient initially refused the picc. after discussion with his attending gi md, he was agreeable to the procedure. he was maintained on this regimen for almost 2 weeks to decrease fistula output, decrease inflammation indicated by a normal wbc. . hd4-11:he required encouragement & constant reminders to keep npo. he had a picc line inserted on , and started on tpn. he was evaluated per nutrition, and recommedations were provided for adequate tpn formulation. he tolerated the tpn well. fistula/ostomy output decreased. he was seen by the ostomy rn for ostomy/fistula care (refer to note in omr). after discussion between gi and gen surgery attending with patient, surgery was scheduled for thursday . on , he was seen by ostomy rn for new stoma site marking. . hd12/pod0-he went to the or for 1. laparotomy, extensive lysis of adhesions, takedown ileostomy, resection of ileostomy and terminal ileum and reciting of ileostomy to the left lower quadrant.2. reconstruction of the abdominal wall using surgisis patches. his operative course was extensive due to adhesions, but uncomplicated, and he was routinely monitored in the pacu. . pain:his pain was an issue throughout this admission. he has a h/o chronic pain issues. he was managed on multiple agents including his home regimen when indicated. he rated his pain between . he did report relief with pain medication regimen, but required frequent breakthrough pain medication. the acute pain service was consulted for post-op pain management. he was started on a bupiv epidural and iv dilaudid pca. his pain was not well managed. ketamin was added to pca, and his pain was better managed temporarily. he became tachycardic in pacu, bolused with decrease in hr. his pain continue to be an issue. he was transferred to icu for pain managment and fever elevation to 103. . icu/pod1-4-his temp was treated with iv antibiotics. his blood pressure was managed with iv lopressor. repeat cultures were collected, and pain was managed with iv ketamine drip. chronic pain service was consulted, and followed his case to discharge. he was re-started on tpn. otherwise stable, and transferred to . . /pod5-discharge:he remained a/ox3 on floor. both his cardiac and respiratory status remained stable. his anit-hypertensives were discontinued. his abdomen was appropriately tender. his incision was ota. his stoma remained pink & viable with stool production. the ostomy rn continued with teaching. his diet was advanced as his bowel function resumed. he was able to tolerate regular food, and his tpn was weaned.once he was able to tolerate po intake, he was weaned from ketamine drip, and switched to dilaudid pca. his pain medication was transitioned to oral medication per recommendations of chronic pain service. he reported adequate pain control, and was discharged with this regimen. he was to able to ambulate per baseline. he was dicharged home with vna for assessment of stoma and ostomy function. he will follow-up with dr. in 2 weeks, and with gastroenterology. medications on admission: methadone 20mg po tid, percocet 10/325 qid, b12 inj 1000mcg sc q2weeks, remicade 400mg q6weeks (last infusion ), cipro 500mg po bid (started friday ), flagyl 500mg tid (for past 1.5mos per gi due to inc fistula drainage) discharge medications: 1. methadone 10 mg tablet sig: three (3) tablet po tid (3 times a day) for 2 weeks. disp:*126 tablet(s)* refills:*0* 2. zolpidem 5 mg tablet sig: one (1) tablet po hs (at bedtime) as needed for insomnia. 3. hydromorphone 4 mg tablet sig: 1-2 tablets po q4h (every 4 hours) as needed for pain for 2 weeks. disp:*30 tablet(s)* refills:*0* 4. lidocaine 5 %(700 mg/patch) adhesive patch, medicated sig: one (1) adhesive patch, medicated topical daily (daily). 5. gabapentin 300 mg capsule sig: one (1) capsule po tid (3 times a day) for 2 weeks. disp:*42 capsule(s)* refills:*0* discharge disposition: home with service facility: home health and hospice discharge diagnosis: prirmary: crohns, with strictured ileostomy & resultant ec fistulae, peristomal abscess . secondary: anxiety, chronic pain, polytendinomyopathy,perianal fistulae, recurrent sbo's, peristomal abscesses discharge condition: stable tolerating a regular diet adequate pain control with oral medciation discharge instructions: .please call your doctor or return to the er for any of the following: * you experience new chest pain, pressure, squeezing or tightness. * if you are vomiting and cannot keep in fluids or your medications. * you are getting dehydrated due to continued vomiting, diarrhea or other reasons. signs of dehydration include dry mouth, rapid heartbeat or feeling dizzy or faint when standing. * you see blood or dark/black material when you vomit or have a bowel movement. * your skin, or the whites of your eyes become yellow. * your pain is not improving within 8-12 hours or becoming progressively worse, or inadequately controlled with the prescribed pain medication. * you have shaking chills, or a fever greater than 101.5 (f) degrees or 38(c) degrees. * any serious change in your symptoms, or any new symptoms that concern you. followup instructions: 1. please follow-up with dr. in 2 weeks. 2. please follow-up with dr. , pain clinic, in 2 weeks. 3. please follow-up with your primary care doctor as needed. procedure: venous catheterization, not elsewhere classified parenteral infusion of concentrated nutritional substances other partial resection of small intestine other lysis of peritoneal adhesions revision of stoma of small intestine other repair of abdominal wall diagnoses: other postoperative infection cellulitis and abscess of trunk other specified intestinal obstruction peritoneal adhesions (postoperative) (postinfection) fistula of intestine, excluding rectum and anus regional enteritis of small intestine infection of colostomy or enterostomy other acute postoperative pain 

Answer: The patient is high likely exposed to